Immunochem

–/10Traction

This company utilizes its EVOBodies™ platform, combining AI and biological tools, to generate single-domain antibodies (VHH) and minibinders against any antigen. They offer bio-pharmaceutical companies a predictable, accelerated workflow to obtain precise antigen-binding molecules in six weeks. This service streamlines research processes by eliminating the uncertainty and time associated with traditional antibody generation campaigns.

HQ unknown

Updated 4 months ago

Funding

Funding rounds are not available yet.

Founders

Founder details are not available yet.

Product

Features

This company utilizes its EVOBodies™ platform, combining AI and biological tools, to generate single-domain antibodies (VHH) and minibinders against any antigen. They offer bio-pharmaceutical companies a predictable, accelerated workflow to obtain precise antigen-binding molecules in six weeks. This service streamlines research processes by eliminating the uncertainty and time associated with traditional antibody generation campaigns.